Literature DB >> 571220

Management of suspected malignant hyperpyrexia in an infant.

D K Faust, S D Gergis, M D Sokoll.   

Abstract

A case of possible malignant hyperthermia in a 6-month-old child is presented. Malignant hyperthermia was manifested in this patient by persistent metabolic acidosis in the intraoperative and postoperative periods, by a rapid rise in temperature with concomitant unresponsiveness in the postoperative period, and by a positive caffeine-halothane stimulation test. The malignant hyperthermia occurring in the postoperative period resolved promptly following administration of dantrolene sodium. An unusual aspect of this case is that both of the child's parents had normal CPK values and negative caffeine-halothane stimulation tests.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571220     DOI: 10.1213/00000539-197901000-00011

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

Review 1.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 2.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

3.  Postoperative malignant hyperthermia and dantrolene therapy.

Authors:  U Schulte-Sasse; W Hess; H J Eberlein
Journal:  Can Anaesth Soc J       Date:  1983-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.